US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

122.85

+1.481.22%

Post-market: 123.030.1800+0.15%19:56 EST

Volume:8.95M

Turnover:1.10B

Market Cap:8.14B

PE:6.74

High:123.47

Open:121.55

Low:120.96

Close:121.37

52wk High:123.47

52wk Low:66.66

Shares:66.30M

Float Shares:62.93M

Volume Ratio:0.79

T/O Rate:14.22%

Dividend:0.04

Dividend Rate:0.03%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

China Reform Health Management and Services to Fully Acquire Two Sub-Units

MT Newswires Live

Health Care Roundup: Market Talk

Healthcare Tech Provider Lac Med Prices IPO Shares

MT Newswires Live

Equity Offering Could Be a Game Changer for American Healthcare REIT (AHR)

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: ProMIS Neurosciences (PMN) and Crispr Therapeutics AG (CRSP)

Sell Recommendation for ImageneBio Due to Strategic Risks and Financial Challenges

Centene (CNC): Is the Healthcare Giant Fairly Valued After Recent Share Price Recovery?

Simply Wall St.

Will DHC’s Debt Reduction Plan Reshape Its Long-Term Flexibility and Value Proposition?

Simply Wall St.

ASX Midday Sector Update: Healthcare Stocks Rise, Communication Services Inch Down

MT Newswires Live

Analysts Are Bullish on These Healthcare Stocks: Fisher & Paykel Healthcare Corporation Limited (FSPKF), 3SBio (TRSBF)

SoftMedx Healthcare Insiders Got A Good Deal Selling At HK$0.01

Simply Wall St.

LENZ Therapeutics to Present at Upcoming Investor Conferences

Fisher & Paykel Healthcare Reports Strong First Half Growth

Promising Potential of Ulixacaltamide in Essential Tremor Market Justifies Buy Rating

Techstep Partners with Tellu to Enhance Digital Healthcare in Norway

Warren Buffett Said Ballooning Healthcare Costs Are A 'Hungry Tapeworm' Eating the Economy —'The Single Biggest Variable' Throwing Us 'Out of Whack'

Benzinga_recent_news

Analysts Are Bullish on These Healthcare Stocks: Simulations Plus (SLP), Inotiv (NOTV)

Should Instacart’s (CART) WellTheory Partnership Prompt a Rethink of Its Healthcare Ambitions?

Simply Wall St.

Sector Update: Health Care Stocks Edge Higher Premarket Tuesday

MT Newswires Live

Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/XBI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":122.85,"timestamp":1764190800000,"preClose":121.37,"halted":0,"volume":8946559,"hourTrading":{"tag":"盘后","latestPrice":123.03,"preClose":122.85,"latestTime":"19:56 EST","volume":102305,"amount":12563957.4929,"timestamp":1764205013938},"delay":0,"floatShares":62925000,"shares":66300000,"eps":18.23,"marketStatus":"Closed Thanksgiving Day","change":1.48,"latestTime":"11-26 16:00:00 EST","open":121.55,"high":123.47,"low":120.955,"amount":1096379602.10517,"amplitude":0.020722,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1764320400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":121.37,"sharesOutstanding":66300000,"nav":121.371028,"aum":8046899163.46,"dividendRate":0.000342,"bidAskSpread":0.000143,"preHourTrading":{"tag":"盘前","latestPrice":121.49,"preClose":121.37,"latestTime":"09:29 EST","volume":5094,"amount":619134.0514560001,"timestamp":1764167399999},"postHourTrading":{"tag":"盘后","latestPrice":123.03,"preClose":122.85,"latestTime":"19:56 EST","volume":102305,"amount":12563957.4929,"timestamp":1764205013938},"volumeRatio":0.7942239994565753,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1771563600000,"strike":"100.0","timestamp":1764177771261,"price":1.5,"volume":15000,"amount":2250000,"type":"+"},{"symbol":"XBI","call":false,"expireDate":1771563600000,"strike":"115.0","timestamp":1764177771261,"price":4.75,"volume":15000,"amount":7125000,"type":"+"}]},"impliedVol":0.3024,"impliedVolPercentile":0.548},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":62925000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7942239994565753,"shares":66300000,"dividePrice":0.042,"high":123.47,"amplitude":0.020722,"preClose":121.37,"low":120.955,"week52Low":66.66,"pbRate":"--","week52High":123.47,"institutionHeld":0.8511,"latestPrice":122.85,"eps":18.23,"divideRate":0.000342,"volume":8946559,"delay":0,"ttmEps":18.23,"open":121.55,"prevYearClose":90.06,"prevWeekClose":116.65,"prevMonthClose":112.71,"prevQuarterClose":100.2,"fiveDayClose":114.5,"twentyDayClose":110.96,"sixtyDayClose":93.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"},{"date":"2024-12-23","symbol":"XBI","amount":0.002687,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-26"},{"date":"2024-09-23","symbol":"XBI","amount":0.015228,"announcedDate":"2024-09-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-23","defaultRemindTime":1727098200000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-25","payableDate":"2024-09-23","currency":"USD","dateTimestamp":1727064000000,"payDate":"2024-09-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2015-12-18","recordDate":"2015-12-22","paymentDate":"2015-12-29","value":0.148677,"currency":"USD"},{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-29","value":0.057833,"currency":"USD"},{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-27","value":0.045491,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586253892","title":"China Reform Health Management and Services to Fully Acquire Two Sub-Units","url":"https://stock-news.laohu8.com/highlight/detail?id=2586253892","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586253892?lang=en_us&edition=fundamental","pubTime":"2025-11-26 18:13","pubTimestamp":1764152003,"startTime":"0","endTime":"0","summary":"China Reform Health Management and Services Group  agreed to acquire two sub-units from its subsidiaries for no consideration, according to a Shenzhen bourse filing on Tuesday.The Chinese health and medical insurance company's shares slipped over 1% at the close of Wednesday's trade.The subsidiary, Guoxin Healthcare Security Service, will transfer the entire shares of Guoxin Healthcare Security Service , while another subsidiary, Hainan Haihong Investment Consulting, will transfer 80% of Hainan Weihong Pharmaceutical E-commerce to the company.After completion, the company will fully own both Guoxin Healthcare Guangdong and Hainan Weihong.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4581","BK4585","BK0097","BK0070","BK0217","XLV","000503","BK0137","BK0188","LABU","BK0146","XBI","BK0114"],"gpt_icon":0},{"id":"2586370892","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2586370892","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586370892?lang=en_us&edition=fundamental","pubTime":"2025-11-26 17:20","pubTimestamp":1764148800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.2214 GMT - Citi analyst Laura Sutcliffe remains cautious on Ramsay Health Care despite the private-hospital operator's stronger-than-expected 1Q revenue and earnings. She points out in a note to clients that the Australian company's September-quarter performance is influenced by hospitalizations from the country's flu season. Sutcliffe raises her full-year Australia Ebit margin to 9.3% to 8.8%, but declines to fully translate the 1Q beat across the whole of fiscal 2026. Investors would like to see Ramsay give explicit margin targets, she adds. Citi lifts its target price 9.1% to A$36.00 and keeps a neutral rating on the stock. Shares are at A$35.95 ahead of the open. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LABU","XBI","BK4581","BK4585","BK4588"],"gpt_icon":0},{"id":"2586323917","title":"Healthcare Tech Provider Lac Med Prices IPO Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586323917","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586323917?lang=en_us&edition=fundamental","pubTime":"2025-11-26 15:43","pubTimestamp":1764142996,"startTime":"0","endTime":"0","summary":"Lac Med  priced the initial public offering shares at 0.75 ringgit apiece, following the completion of bookbuilding under the institutional offering, according to a Wednesday Malaysian bourse filing.According to earlier filings, the IPO comprises a public issue of 74.2 million shares at 0.22 ringgit each, as well as an offer-for-sale of 30 million shares.Proceeds will be used for expansion, to boost working capital, and to pay off expenses, the healthcare technology provider said.The retail offering closed at 5:00 p.m. on Nov. 25.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","LABU","LU0029874061.USD","HCSG","BK4588","BK4585","XBI","XLV","LU0128526141.USD","BK4137"],"gpt_icon":1},{"id":"2586816230","title":"Equity Offering Could Be a Game Changer for American Healthcare REIT (AHR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2586816230","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586816230?lang=en_us&edition=fundamental","pubTime":"2025-11-26 15:28","pubTimestamp":1764142108,"startTime":"0","endTime":"0","summary":"American Healthcare REIT, Inc. recently filed a follow-on equity offering, registering 8,100,000 shares of common stock with income trust features.\nThis move draws attention to the company's capital raising efforts and the potential effects on existing shareholder dilution and future growth strategy.\nWe'll explore how the newly announced equity offering could influence American Healthcare REIT's ability to fund acquisitions and drive portfolio expansion.\nFind companies with promising cash...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-ahr/american-healthcare-reit/news/equity-offering-could-be-a-game-changer-for-american-healthc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-ahr/american-healthcare-reit/news/equity-offering-could-be-a-game-changer-for-american-healthc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4215","BK4585","BK4588","CFA.SI","XLV","AHR","BK4581","8C8U.SI","XBI","BK6142","EQR","REIT","BK4225","LABU"],"gpt_icon":0},{"id":"2586582235","title":"Analysts Offer Insights on Healthcare Companies: ProMIS Neurosciences (PMN) and Crispr Therapeutics AG (CRSP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2586582235","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586582235?lang=en_us&edition=fundamental","pubTime":"2025-11-26 14:30","pubTimestamp":1764138618,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ProMIS Neurosciences (PMN – Research Report) and Cri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-promis-neurosciences-pmn-and-crispr-therapeutics-ag-crsp-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-promis-neurosciences-pmn-and-crispr-therapeutics-ag-crsp-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","BK4210","BK4139","AG","CRSP","LU0128526141.USD","LU0029874061.USD","BK4611","XBI","BK4137","BK4585","PMN","BK4556","HCSG","LABU","LU1861559042.SGD","XLV","BK4588","BK4581"],"gpt_icon":0},{"id":"2586280667","title":"Sell Recommendation for ImageneBio Due to Strategic Risks and Financial Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2586280667","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586280667?lang=en_us&edition=fundamental","pubTime":"2025-11-26 12:55","pubTimestamp":1764132914,"startTime":"0","endTime":"0","summary":"ImageneBio, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Martin Fan from Wedbush downgraded the rating ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sell-recommendation-for-imagenebio-due-to-strategic-risks-and-financial-challenges-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sell-recommendation-for-imagenebio-due-to-strategic-risks-and-financial-challenges-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","BK4585","XBI","BK4581","LABU"],"gpt_icon":0},{"id":"2586280067","title":"Centene (CNC): Is the Healthcare Giant Fairly Valued After Recent Share Price Recovery?","url":"https://stock-news.laohu8.com/highlight/detail?id=2586280067","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586280067?lang=en_us&edition=fundamental","pubTime":"2025-11-26 12:42","pubTimestamp":1764132164,"startTime":"0","endTime":"0","summary":"Centene (CNC) shares have seen modest movement recently, with the stock up 4% over the past month. Investors may be considering how ongoing developments in healthcare and the company’s improving annual revenue growth factor into current share prices.\nSee our latest analysis for Centene.\nAfter a tough stretch earlier this year, Centene's recent momentum is hard to ignore, with a 16.4% 1-month share price return and a sharp rebound of 37.5% over the past 90 days. Still, the 1-year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/26273-main-header/1756252774034","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/26273-main-header/1756252774034"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cnc/centene/news/centene-cnc-is-the-healthcare-giant-fairly-valued-after-rece","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cnc/centene/news/centene-cnc-is-the-healthcare-giant-fairly-valued-after-rece","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XBI","BK4585","BK4154","LU1201861165.SGD","LU0477156953.USD","HCSG","LU1201861249.SGD","LABU","BK4588","LU0128526141.USD","LU0477156797.USD","LU0130102774.USD","LU2362541273.HKD","BK4581","LU1989771016.USD","LU2362540622.SGD","LU0130518102.USD","IE0034235188.USD","LU1291159041.SGD","LU0648001328.SGD","BK4137","LU0130517989.USD","LU0029874061.USD","LU2362541513.USD","LU0130103400.USD","LU0980610538.SGD","LU1699723380.USD","XLV","LU0648000940.SGD","CNC"],"gpt_icon":0},{"id":"2586856238","title":"Will DHC’s Debt Reduction Plan Reshape Its Long-Term Flexibility and Value Proposition?","url":"https://stock-news.laohu8.com/highlight/detail?id=2586856238","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586856238?lang=en_us&edition=fundamental","pubTime":"2025-11-26 12:42","pubTimestamp":1764132135,"startTime":"0","endTime":"0","summary":"Citizens recently reiterated its Market Perform rating on Diversified Healthcare Trust after the company released its third-quarter 2025 results, highlighting improvements in its senior housing operating portfolio, including increased year-over-year occupancy despite earlier disruptions.\nA unique aspect of this update is management's clear plan to address high-cost debt by the first quarter of 2026, using asset sales and a credit facility to significantly enhance financial flexibility.\nWe'll...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/will-dhcs-debt-reduction-plan-reshape-its-long-term-flexibil","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/will-dhcs-debt-reduction-plan-reshape-its-long-term-flexibil","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XBI","LABU","BK4225","BK4203","DHC","BK4585","BK4581","BK4588","XLV"],"gpt_icon":0},{"id":"2586890402","title":"ASX Midday Sector Update: Healthcare Stocks Rise, Communication Services Inch Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2586890402","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586890402?lang=en_us&edition=fundamental","pubTime":"2025-11-26 10:33","pubTimestamp":1764124424,"startTime":"0","endTime":"0","summary":"The healthcare sector rose over 1% at midday Wednesday.Australia's consumer price index (CPI) rose 3.8% in the 12 months to October, up from a 3.6% gain in the year to September, dampening expectation","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ART.AU","BK4137","BK4581","FPH.AU","XBI","WIMI","BK7002","BK7501","XLV","BK7007","CPI","LU0128526141.USD","BK4009","BK4585","LABU","BK4588","HCSG","LU0029874061.USD"],"gpt_icon":0},{"id":"2586288283","title":"Analysts Are Bullish on These Healthcare Stocks: Fisher & Paykel Healthcare Corporation Limited (FSPKF), 3SBio (TRSBF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2586288283","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586288283?lang=en_us&edition=fundamental","pubTime":"2025-11-26 08:30","pubTimestamp":1764117017,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Fisher & Paykel Healthcare Corporation Limited (FSPK...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-fisher-paykel-healthcare-corporation-limited-fspkf-3sbio-trsbf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-fisher-paykel-healthcare-corporation-limited-fspkf-3sbio-trsbf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK8004","BK4139","FSPKF","FPH.NZ","XBI","LABU","XLV","BK4588","BK4585","BK4082","TRSBF","BK4112"],"gpt_icon":0},{"id":"2586283854","title":"SoftMedx Healthcare Insiders Got A Good Deal Selling At HK$0.01","url":"https://stock-news.laohu8.com/highlight/detail?id=2586283854","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586283854?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:24","pubTimestamp":1764109443,"startTime":"0","endTime":"0","summary":"While it’s been a great week for SoftMedx Healthcare Limited ( HKG:648 ) shareholders after stock gained 18%, they...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-648/softmedx-healthcare-shares/news/softmedx-healthcare-insiders-got-a-good-deal-selling-at-hk00","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-648/softmedx-healthcare-shares/news/softmedx-healthcare-insiders-got-a-good-deal-selling-at-hk00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00648","BK4585","XBI","XLV","BK4581","BK1511","LU0128526141.USD","BK1219","LABU","LU0029874061.USD","BK4137","HCSG","BK4588"],"gpt_icon":0},{"id":"2586095544","title":"LENZ Therapeutics to Present at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2586095544","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586095544?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:05","pubTimestamp":1764104700,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Nov.  25, 2025  (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalm","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/25/3194718/0/en/LENZ-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4581","BK4539","BK4139","XBI","LABU","LENZ","XLV","BK4585","BK4588"],"gpt_icon":0},{"id":"2586406214","title":"Fisher & Paykel Healthcare Reports Strong First Half Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2586406214","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586406214?lang=en_us&edition=fundamental","pubTime":"2025-11-26 04:42","pubTimestamp":1764103352,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Fisher & Paykel Healthcare Corporation Limited ( ($FSPKF) ). Fisher & Paykel Healthcare Corporation Limited rep...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-reports-strong-first-half-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-reports-strong-first-half-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XBI","FPH.NZ","BK4585","BK4581","LABU","BK8004","XLV"],"gpt_icon":0},{"id":"2586470609","title":"Promising Potential of Ulixacaltamide in Essential Tremor Market Justifies Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2586470609","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586470609?lang=en_us&edition=fundamental","pubTime":"2025-11-26 00:45","pubTimestamp":1764089119,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Francois Brisebois from LifeSci Ca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-potential-of-ulixacaltamide-in-essential-tremor-market-justifies-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-potential-of-ulixacaltamide-in-essential-tremor-market-justifies-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","PRAX","XLV","BK4581","BK4139","BK4585","BK4588","LU0320765992.SGD","LU0109394709.USD","LABU","XBI"],"gpt_icon":0},{"id":"2586547264","title":"Techstep Partners with Tellu to Enhance Digital Healthcare in Norway","url":"https://stock-news.laohu8.com/highlight/detail?id=2586547264","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586547264?lang=en_us&edition=fundamental","pubTime":"2025-11-25 23:33","pubTimestamp":1764084791,"startTime":"0","endTime":"0","summary":"The latest update is out from Techstep ASA ( ($DE:B1T0) ). Techstep has partnered with Tellu to launch a managed device-as-a-service solution aimed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/techstep-partners-with-tellu-to-enhance-digital-healthcare-in-norway?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/techstep-partners-with-tellu-to-enhance-digital-healthcare-in-norway?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4585","XBI","LU0029874061.USD","LABU","BK4588","XLV","BK4137","BK4581","LU0128526141.USD"],"gpt_icon":0},{"id":"2586474556","title":"Warren Buffett Said Ballooning Healthcare Costs Are A 'Hungry Tapeworm' Eating the Economy —'The Single Biggest Variable' Throwing Us 'Out of Whack'","url":"https://stock-news.laohu8.com/highlight/detail?id=2586474556","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586474556?lang=en_us&edition=fundamental","pubTime":"2025-11-25 23:00","pubTimestamp":1764082800,"startTime":"0","endTime":"0","summary":"Millions of Americans watch their paychecks shrink under premiums, deductibles, and medical bills that rise faster than their wages. Warren Buffett, the longtime Berkshire Hathaway CEO, drew a straight line between those bills and the country's economic standing.At Berkshire's 2017 shareholder meeting, he told investors that healthcare costs had become a direct threat to American competitiveness.Those comments created an unmistakable spotlight on the forces driving costs higher. They also set the stage for one of the most ambitious corporate partnerships in recent memory. In early 2018, Amazon, Berkshire Hathaway, and JPMorgan Chase announced an independent nonprofit created to tackle healthcare spending for their workers.Family coverage has become one of the sharpest pressure points in employer insurance. According to the Kaiser Family Foundation's annual employer health benefits survey, the average f","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/25/Cuban-Calls-For-Caution-On-Universal-Hea.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/25/Cuban-Calls-For-Caution-On-Universal-Hea.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/personal-finance/management/25/11/49057727/warren-buffett-said-ballooning-healthcare-costs-are-a-hungry-tapeworm-eating-the-economy-the-single-biggest-variable-throwing-us-out-of-whack","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/personal-finance/management/25/11/49057727/warren-buffett-said-ballooning-healthcare-costs-are-a-hungry-tapeworm-eating-the-economy-the-single-biggest-variable-throwing-us-out-of-whack","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0029874061.USD","LU2168563687.JPY","IE00BKDWB100.SGD","LU0980610538.SGD","LU1914381329.SGD","LU2168564149.EUR","LU2168564222.USD","IE00B1BXHZ80.USD","LU0742534661.SGD","LABU","IE00BJLML261.HKD","LU0053666078.USD","LU0234570918.USD","LU2168564495.EUR","XBI","BRK.A","LU0048573561.USD","BK4585","LU0170899867.USD","LU0971096721.USD","LU1363072403.SGD","LU1571399168.USD","LU0256863811.USD","IE0034235303.USD","BK4588","BK4581","LU0154236417.USD","LU0648001328.SGD","LU0149725797.USD","LU0640476718.USD","LU2487616109.SGD","LU1201861249.SGD","LU0787776722.HKD","HCSG","LU0130102774.USD","BRK.B","LU0157215616.USD","LU0128526141.USD","IE00BK4W5M84.HKD","BK4137","IE000M9KFDE8.USD","IE00BK4W5L77.USD","LU1280957306.USD","XLV","IE00B775SV38.USD","BK4533","BK4534","LU0251131958.USD","LU0417517546.SGD","BK4176"],"gpt_icon":1},{"id":"2586474581","title":"Analysts Are Bullish on These Healthcare Stocks: Simulations Plus (SLP), Inotiv (NOTV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2586474581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586474581?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:40","pubTimestamp":1764081622,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Simulations Plus (SLP – Research Report), Inotiv (NO...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-simulations-plus-slp-inotiv-notv-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-simulations-plus-slp-inotiv-notv-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","LU0029874061.USD","XLV","LABU","BK4112","BK4121","BK4581","BK4137","BK4585","SLP","XBI","LU0128526141.USD","BK4588","NOTV","HCSG"],"gpt_icon":0},{"id":"2586721864","title":"Should Instacart’s (CART) WellTheory Partnership Prompt a Rethink of Its Healthcare Ambitions?","url":"https://stock-news.laohu8.com/highlight/detail?id=2586721864","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586721864?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:33","pubTimestamp":1764081227,"startTime":"0","endTime":"0","summary":"WellTheory recently announced a partnership with Instacart to give roughly 300,000 autoimmune care members access to Instacart Health Fresh Funds, enabling the purchase of clinically recommended groceries through Instacart’s nationwide network.\nThis collaboration highlights Instacart’s increasing role in the food-as-medicine movement, extending its reach into virtual healthcare and addressing key barriers to nutritious food access for vulnerable populations.\nWith Instacart’s Fresh Funds...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/5023000-choice1-main-header/1585186815097","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5023000-choice1-main-header/1585186815097"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-retailing/nasdaq-cart/maplebear/news/should-instacarts-cart-welltheory-partnership-prompt-a-rethi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-retailing/nasdaq-cart/maplebear/news/should-instacarts-cart-welltheory-partnership-prompt-a-rethi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","BK4585","BK4113","LU0128526141.USD","BK4137","XLV","BK4588","HCSG","LU0029874061.USD","CART","XBI","LABU"],"gpt_icon":0},{"id":"2586747944","title":"Sector Update: Health Care Stocks Edge Higher Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2586747944","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586747944?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:21","pubTimestamp":1764080485,"startTime":"0","endTime":"0","summary":"Health care stocks were edging higher premarket Tuesday, with the iShares Biotechnology ETF  up 0.7% and the Health Care Select Sector SPDR Fund  up 0.3%.Novartis  shares were up more than 1% after the company said the US Food and Drug Administration has approved itvisma to treat spinal muscular atrophy, or SMA. Separately, Novartis plans to cut up to 550 full-time jobs by the end of 2027 at its Stein facility in northern Switzerland, Reuters reported, citing the company.Novo Nordisk  stock was up more than 2% after the company said a phase 2 trial of its experimental drug amycretin in people with type 2 diabetes showed reductions in weight and HbA1c or average blood sugar.Select Medical Holdings  shares were 14% higher after the company said it has received a non-binding indication of interest from Executive Chairman and co-Founder Robert Ortenzio to acquire all the outstanding shares of the company for between $16 and $16.20 per common share in cash.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4578","IE00B2B36J28.USD","IE00BZ1G4Q59.USD","IE0002141913.USD","LU0211331839.USD","IBB","BK4599","IE00B4R5TH58.HKD","NVO","IE0009355771.USD","LU0070302665.USD","LU0320765489.SGD","BK4185","LABU","SEM","IE00BKVL7J92.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK7104","NVO.AU","BK4007","IE00BFTCPJ56.SGD","NVS","BK4532","XLV","XBI","LU1093756168.USD","BK4588","LU0154236417.USD","LU0208291251.USD","BK4581","LU1093756325.SGD","BK4585"],"gpt_icon":1},{"id":"2586247645","title":"Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2586247645","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586247645?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:45","pubTimestamp":1764078300,"startTime":"0","endTime":"0","summary":"Live webcast fireside chat on Thursday, December 4th at 10:30 AM ET Carlsbad,CA, Nov.  25, 2025  (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage b","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/25/3194353/0/en/Palisade-Bio-to-Present-at-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","XBI","XLV","LABU","HCSG","BK4581","LU0029874061.USD","BK4585","BK4588","BK4137"],"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":2,"totalSize":273,"code":"91000000","status":"200"}]}}